Krystal (KRYS) falls 1.76%
Today, Krystal Biotech Inc Inc’s (NASDAQ: KRYS) stock fell $0.91, accounting for a 1.76% decrease. Krystal opened at $51.64 before trading between $52.64 and $50.62 throughout Monday’s session. The activity…
From the Equity Insider archive. This article dates from Oct 12, 2021 and is preserved as first published.
Today, Krystal Biotech Inc Inc’s (NASDAQ: KRYS) stock fell $0.91, accounting for a 1.76% decrease. Krystal opened at $51.64 before trading between $52.64 and $50.62 throughout Monday’s session. The activity saw Krystal’s market cap fall to $1,125,603,993 on 94,034 shares -below their 30-day average of 109,268.
About Krystal Biotech Inc
The activity saw Krystal’s market cap fall to $1,125,603,993 on 94,034 shares -below their 30-day average of 109,268.
Krystal Biotech, Inc. is a pivotal-stage gene therapy company leveraging its novel, redosable gene therapy platform and in-house manufacturing capabilities to develop therapies to treat serious rare diseases.
